Delivery Order SPE2DR25D3015-SPE2DR26F4EU7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) valued at $1,338.19 on April 21, 2025, with an ultimate completion date of April 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count) on October 16, 2025, with a ceiling value of $1,743.64 and an ultimate completion date of October 17, 2025. This non-set-aside, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $3,899.68 delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Qulipta 60 mg tablets (quantity: 30 tablets). This is a firm fixed-price, competitively awarded contract with performance at the contractor's Conshohocken, Pennsylvania location and an ultimate completion date of November 13, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,420.07 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Qulipta 60 mg tablets (30-count). This firm fixed-price, non-set-aside contract is scheduled for completion by July 21, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order valued at $1,154.79 to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $2,352.97 firm fixed price delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count) on October 21, 2025, with an ultimate completion date of October 22, 2025. This non-set-aside contract is being performed in Conshohocken, Pennsylvania, where the awardee maintains its corporate office. The delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $3,176.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Qulipta 30 mg tablets (30-count units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-set-aside contract award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,629.76 to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitive award, which utilized firm fixed-price pricing with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,319.71 to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count supply) on November 20, 2025, with an ultimate completion date of November 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency (DLA) awarded a $3,134.47 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price, competitively awarded contract (no set-aside) is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D3015Indefinite Delivery Contract
- SPE2DR25D3015-SPE2DR26F4EU7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,962.72 to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) on November 20, 2025, with an ultimate completion date of November 21, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply agreement running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part of its extensive portfolio of pharmaceutical deliveries to military and veteran healthcare systems. The company's IDC serves as a global pharmaceutical support vehicle enabling supply of brand-name and generic medications, vaccines, and specialty medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers. This particular delivery order for Qulipta, an atypical antipsychotic medication, reflects AmerisourceBergen's continued role in supplying neurological and psychiatric treatment options through the DLA's medical supply chain.